Chemical Compound

Levofloxacin Q-Acid

CAS Registry Number 100986-89-8

Back to search Request a Quote

Primary Record

Levofloxacin Q-Acid

In stock: 824 g
Purity: 99.4 %
CAS: 100986-89-8

Compound Identifiers & Properties

CAS: 100986-89-8
PubChem CID: 688333
SMILES: C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2F)F)C(=O)O
Canonical SMILES: C[C@H]1COc2c(F)c(F)cc3c(=O)c(C(=O)O)cn1c23

Names & Synonyms

Levofloxacin Q-Acid
Levofloxacin carboxylic acid
100986-89-8
Levofloxacin acid
Levofloxacin Q acid
Levofloxacin related compound B
Oxygen-fluorine acid
Ofloxacin Impurity A
Levofloxacin q-acid, (-)-
Levofloxacin impurity F
UNII-08GT8FY84E
Levofloxacin Impurity A
Levefluorocarboxylic Acid
Levofloxacin EP Impurity F
AC1LELV0
RefChem:153208
08GT8FY84E
MFCD04039905
C13H9F2NO4
Levofloxacin impurity F CRS
Levofloxacin Q-acid =97%
(S)-9,10-Difluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
DTXSID60143604
NVKWWNNJFKZNJO-YFKPBYRVSA-N
IFLab1_001868
orb3027198
SCHEMBL2333806
DTXCID9066095
Levofloxacin related compound B
Levofloxacin related compound B [USP]
SCHEMBL29872315
CTK0H4797
ZINC57096
CHEBI:167723
Levofloxacin related compound B RS [USP]
KS-00000H1D
ANW-58925
CID688333
EBC-58052
AKOS016002127
Levofloxacin related compound B (USP)
AC-7592
ACN-038327
FS-4544
IL24882
Levofloxacin Q-acid, 98% - 1G 1g
AJ-09575
BC209423
SC-15832
SY066902
Levofloxacin related compound B RS (USP)
AB0088529
J795.481F
Levofloxacin Impurity F CRS (Y0002084)
LEVOFLOXACIN RELATED COMPOUND B [USP-RS]
CS-0136444
FT-0602614
FT-0642442
L0238
(2S)-6,7-difluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
86D898
N17092
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-, (3S)-
EN300-1655914
Levofloxacin Carboxylic Acid (Levofloxacin Difluoro Impurity)
LEVOFLOXACIN RELATED COMPOUND B (USP-RS)
LEVOFLOXACIN RELATED COMPOUND B [USP IMPURITY]
(S)-(-)-910-DIFLRO-23-DIHYD 1G.
(S)-(-)-910-DIFLRO-23-DIHYD 5G.
A897275
F222352
LEVOFLOXACIN HEMIHYDRATE IMPURITY F [EP IMPURITY]
(S)-(-)-910-DIFLRO-23-DI 250MG.
LEVOFLOXACIN RELATED COMPOUND B (USP IMPURITY)
Q27236408
(S)-(-)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acid
7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-, (3S)-
LEVOFLOXACIN HEMIHYDRATE IMPURITY F (EP IMPURITY)
Z2681131293
(3S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
(S)-(-)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
Levofloxacin EP Impurity F; USP Levofloxacin Related Compound B
(-)-9,10-difluoro-3(S)-methyl-7-oxo-2,3-dihydro-7H- pyrido (1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(3S)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
(S)-(-)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido-[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
(S)-9,10-DIFLUORO-3-METHYL-7-OXO-2,3-DIHYDRO-7H-PYRIDO(1,2,3-DE)(1,4)BENZOXAZINE-6-CARBOXYLIC ACID
(S)-9,10-Difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
2,6-DICHLORO-4-(3-(1,1-DIMETHYLETHYL)-5-OXAZOLIDINYL)BENZENAMINE
82419-35-0
8,9-difluoro-3-methyl-6-oxo-2,3-dihydro-6H-1-oxa-3a-azaphenalene-5-carboxylic acid
Levofloxacin Related Compound B, United States Pharmacopeia (USP) Reference Standard
(-) -9,10-difluoro-3(S)-methyl-7-oxo-2,3-dihydro-7H -pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
(-) -9,10-difluoro-3(S)-methyl-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
(-)-9,10-difluoro-3(S)-methyl-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
(-)-9,10-difluoro-3(S)-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
(2S)-6,7-difluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.0,5,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
(3S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzooxazine-6-carboxylic acid
(3S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (S)-(-)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid; 9,10-Difluoro-3-(S)-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; Levofloxacin Q-acid; Levofloxacin Related Compound B; Levofloxacin Hemihydrate Impurity F
(3S)-9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
(3S)-9,10-Difluoro-2,3-dihydro-3alpha-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
(3S)-9,10-Difluoro-3-methyl-2,3-dihydro-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzooxazine-6-carboxylic acid
(3S)-9,10-Difluoro-3-methyl-7-oxo-2,3-dihydro-7H-1,4-oxazino[2,3,4-ij]quinoline-6-carboxylic acid
(S)-(-) 9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4] benzoxazine-6-carboxylic acid
(S)-(-)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid 97%
(S)-(-)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 97%
(S)-(-)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de] [1,4]benzoxazine-6-carboxylic acid
(S)-(-)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de][1,4]benzoxazine-6-carboxylic acid
(S)-(-)-9,10-Difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
(S)-(-)-9,10-Difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
(S)-9,10-Difluro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
6,7-diluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylicacid, 9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-, (3S)-
9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-(3S)-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
923-011-0